JW (Cayman) Therapeutics Co. Ltd. (HK:2126) has released an update.
JW (Cayman) Therapeutics Co. Ltd. successfully conducted its Annual General Meeting on June 18, 2024, where all resolutions, including the adoption of financial statements and re-election of directors, were overwhelmingly passed by shareholders. Notably, the re-appointment of PricewaterhouseCoopers as the company auditor and the authorization for the board to issue additional shares up to 20% of the total issued shares received near-unanimous support.
For further insights into HK:2126 stock, check out TipRanks’ Stock Analysis page.
